Gabapentin in Fibromyalgia Trial (GIFT)

This study has been completed.
Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Fibromyalgia
2		Additional conditions recognized in this trial
			Myofascial Pain Syndromes
3		More general conditions related to this trial
			Muscular Diseases
			Musculoskeletal Diseases
			Nervous System Diseases
			Neuromuscular Diseases
			Rheumatic Diseases
4		Interventions listed in this trial
			gabapentin
5		More general drug interventions related to this trial
			Analgesics
			Anti-Anxiety Agents
			Anti-Dyskinesia Agents
			Anticonvulsants
			Antimanic Agents
			Antiparkinson Agents
			Calcium Channel Blockers
			Cardiovascular Agents
			Central Nervous System Agents
			Central Nervous System Depressants
			Excitatory Amino Acid Agents
			Excitatory Amino Acid Antagonists
			Membrane Transport Modulators
			Molecular Mechanisms of Pharmacological Action
			Neurotransmitter Agents
			Peripheral Nervous System Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Psychotropic Drugs
			Sensory System Agents
			Therapeutic Uses
			Tranquilizing Agents
6		Sponsors listed in this trial
			National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)